Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | ACHE | P22303 | 2/20 | 0.41 |
| ▸ | CA3 | P07451 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | CA6 | P23280 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.38 |
| ▸ | TP53 | P04637 | 3/20 | 0.38 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27043326 | 0.93 | ALDH1A1 (0.52) | MEN1MAPTKMT2AALDH1A1CYP3A4 | |
| SCHEMBL27043327 | 0.87 | APP (0.54) | MEN1MAPTKMT2ANPC1RAB9A | |
| SCHEMBL235602 | 0.85 | NR1I2 (0.43) | NR1I2HPGD | |
| SCHEMBL4516363 | 0.83 | MEN1 (0.44) | MEN1MAPTKMT2AALDH1A1CYP3A4 | |
| SCHEMBL27043325 | 0.83 | APP (0.48) | MEN1MAPTKMT2AALDH1A1CYP3A4 | |
| SCHEMBL7902561 | 0.82 | NR1I2 (0.42) | NR1I2HPGD | |
| SCHEMBL4527473 | 0.77 | ALDH1A1 (0.52) | MEN1MAPTKMT2AALDH1A1CYP3A4 | |
| SCHEMBL65963 | 0.77 | MEN1 (0.50) | MEN1MAPTKMT2AALDH1A1CYP3A4 | |
| SCHEMBL29086820 | 0.77 | NR1I2 (0.39) | NR1I2HPGD | |
| SCHEMBL1172568 | 0.77 | MEN1 (0.50) | MEN1MAPTKMT2AALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210017420-A1 | STRUCTURE BODY, SENSOR, AND METHOD FOR PRODUCING STRUCTURE BODY | DENSO CORPORATION (JP) | 2021-01-21 | — | — | US | claimed |
| WO-2019193943-A1 | STRUCTURE BODY, SENSOR, AND STRUCTURE BODY PRODUCTION METHOD | 株式会社デンソー | 2019-10-10 | — | — | WO | claimed |
| US-11485877-B2 | Structure body, sensor, and method for producing structure body | DENSO CORPORATION (JP) | 2022-11-01 | — | — | US | disclosed |
| US-20210017420-A1 | STRUCTURE BODY, SENSOR, AND METHOD FOR PRODUCING STRUCTURE BODY | DENSO CORPORATION (JP) | 2021-01-21 | — | — | US | disclosed |
| US-20210017420-A1 | STRUCTURE BODY, SENSOR, AND METHOD FOR PRODUCING STRUCTURE BODY | DENSO CORPORATION (JP) | 2021-01-21 | — | — | US | disclosed |
| US-10723845-B2 | Process for preparing linear carbosiloxane polymers | DOW SILICONES CORPORATION (US) | 2020-07-28 | — | — | US | disclosed |
| US-20200079911-A1 | PROCESS FOR PREPARING LINEAR CARBOSILOXANE POLYMERS | DOW CORNING EUROPE S.A. | 2020-03-12 | — | — | US | disclosed |
| EP-3153540-B1 | PROCESS FOR PREPARING LINEAR CARBOSILOXANE POLYMERS | DOW CORNING (US) | 2018-06-06 | — | — | EP | disclosed |
| WO-2017062091-A1 | PROCESS FOR PREPARING LINEAR CARBOSILOXANE POLYMERS | DOW CORNING CORPORATION (US) | 2017-04-13 | — | — | WO | disclosed |
| EP-3153540-A1 | PROCESS FOR PREPARING LINEAR CARBOSILOXANE POLYMERS | Dow Corning Corporation (US) | 2017-04-12 | — | — | EP | disclosed |
| WO-2015106292-A1 | BCR-ABL TYROSINE-KINASE LIGANDS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME | COFERON, INC. (US) | 2015-07-16 | — | — | WO | disclosed |
| US-20140243286-A1 | BROMODOMAIN LIGANDS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME | COFERON, INC. (US) | 2014-08-28 | — | — | US | disclosed |
| US-20140243286-A1 | BROMODOMAIN LIGANDS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME | COFERON, INC. (US) | 2014-08-28 | — | — | US | disclosed |
| US-5286890-A | Aromatic amine terminated silicone monomers, oligomers, and polymers therefrom | HUGHES AIRCRAFT COMPANY (US) | 1994-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140243286-A1 | BROMODOMAIN LIGANDS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME | BRDT, BRD4, BRD1 | MEN1 836/4885MAPT 1845/4885KMT2A 2014/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.